
Odaia
An AI-powered commercial intelligence platform helping pharmaceutical companies optimize their engagement with healthcare providers.
Odaia is a healthtech company, founded in 2018. It has raised $15 million in disclosed funding. Its latest round was a Series C of $15 million in November 2026.
Overview
Founded in 2018, ODAIA provides an AI-driven commercial intelligence platform designed for the biopharmaceutical industry. The company’s software helps pharmaceutical commercial teams transition from fragmented data to actionable insights by unifying their commercial data, AI models, and operational workflows. Its core product suite offers marketing intelligence for automated, personalized digital campaigns and field intelligence to assist sales representatives in prioritizing HCP engagements. By analyzing factors such as patient opportunities and prescribing behavior, ODAIA allows pharma brands to optimize call plans and improve field sales efficiency. Customers include major biopharma companies such as GSK, Bausch Health, and Novo Nordisk. ODAIA operates as a remote-first organization and is focused on reducing time-to-therapy for patients through its software. The company has raised $15M in funding to support its growth as a Series C+ entity. ODAIA’s platform is built to orchestrate the 'next best engagement,' ensuring the right communication reaches the right healthcare provider at the opportune moment.
Funding
Total disclosed: $15M across 1 round. Computed only from sourced rounds.
Investors
Questions and answers
What does Odaia do?
An AI-powered commercial intelligence platform helping pharmaceutical companies optimize their engagement with healthcare providers.
How much has Odaia raised?
Odaia has raised $15 million in disclosed funding across 1 round tracked by OSH.
Who has invested in Odaia?
Investors in Odaia include Monograph Capital, Publicis Health Media, BDC Capital, Flint Capital, Innospark Ventures and 3 more.
When and where was Odaia founded?
Odaia was founded in 2018.
Timeline
Founded
Sources
- 1.Odaia raises $15-million Series C round, inks deal with US health agency — BetaKit, Nov 18, 2026
- 2.Odaia · Official
- 3.Odaia · Official
- 4.Odaia · Official
- 5.Odaia · Official